Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2025)

Intelligent Bio Solutions has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $8.2 million in Q2 2025.

• For the quarter ending Q2 2025, Liabilities and Shareholders Equity fell 40.13% year-over-year to $8.2 million; the trailing twelve-month figure through Jun 2025 stood at $38.2 million (down 20.89% YoY), and the FY2025 full-year result was $8.2 million, down 40.13% from the prior year.
• Liabilities and Shareholders Equity for Q2 2025 stood at $8.2 million, down from $9.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $21.9 million in Q2 2021, with the low at $8.2 million in Q2 2025.
• Average Liabilities and Shareholders Equity over 5 years is $13.1 million, with a median of $12.0 million recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity surged 782.98% in 2021 and plunged 51.09% in 2023.
• Tracing INBS's Liabilities and Shareholders Equity over 5 years: stood at $15.2 million in 2021, then grew by 18.46% to $18.0 million in 2022, then sank by 51.09% to $8.8 million in 2023, then decreased by 1.62% to $8.7 million in 2024, then fell by 5.0% to $8.2 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $8.2 million (Q2 2025), $9.6 million (Q1 2025), and $8.7 million (Q4 2024), per Business Quant data.

Peer Comparison